Semaglutide GLP1 Agonists With Degludec Basal-bolus Insulin in Early Type 1 Diabetes to Basal-bolus

NCT06057077 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

120

Enrollment

OTHER_GOV

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: Semaglutide weekly injection

Sponsor

Ministry of Health, Saudi Arabia